NFKB1 and metabolic syndrome: Its carcinogenic mechanisms primarily involve the synergistic effects of systemic chronic inflammation and metabolic dysregulation: On the one hand, chronic inflammation driven by metabolic syndrome promotes epithelial–mesenchymal transition and angiogenesis through activation of the NF-κB signaling pathway.